Comparing all the reported variants of EIF2AK4 between patients with classic PAH and PVOD, only 3 variants are shared (48), indicating that mutations in different functional domains of GCN2 may play distinct roles in the development of classic PAH and PVOD. The gene discussed is EIF2AK4; the disease is pulmonary arterial hypertension.